LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

Search

NeoGenomics Inc

Atvērts

7.06 2.92

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

6.87

Max

7.17

Galvenie mērījumi

By Trading Economics

Ienākumi

-19M

-45M

Pārdošana

13M

181M

Peļņas marža

-24.867

Darbinieki

2,200

EBITDA

-41M

-48M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+38.66% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 4. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

1.8M

833M

Iepriekšējā atvēršanas cena

4.14

Iepriekšējā slēgšanas cena

7.06

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

NeoGenomics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 26. aug. 16:21 UTC

Galvenie tirgus virzītāji

Hut 8 Shares Rise on Plans for Four New Sites

2025. g. 26. aug. 13:15 UTC

Iegādes, apvienošanās, pārņemšana

Trump Media to Establish Digital-Asset Treasury Company With Yorkville Acquisition, Crypto.com

2025. g. 25. aug. 17:24 UTC

Galvenie tirgus virzītāji

DDC Enterprise Shares Rise on Latest Bitcoin Buy

2025. g. 20. aug. 17:11 UTC

Galvenie tirgus virzītāji

Shineco Rises on Plans to Tokenize Cellular-Therapy Assets

2025. g. 19. aug. 14:44 UTC

Galvenie tirgus virzītāji
Iegādes, apvienošanās, pārņemšana

Thumzup Shares Drop After Deal to Buy Dogecoin-Mining Platform

2025. g. 27. aug. 07:40 UTC

Tirgus saruna

Bitcoin Stays Under Pressure After Hitting Near 7-Week Low -- Market Talk

2025. g. 27. aug. 07:40 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 26. aug. 06:52 UTC

Tirgus saruna

Bitcoin Struggles to Recover From Earlier Losses -- Market Talk

2025. g. 25. aug. 15:58 UTC

Iegādes, apvienošanās, pārņemšana

These Stocks Are Moving the Most Today: Intel, Keurig Dr Pepper, Wayfair, Strategy, Nvidia, Vital Energy, and More -- Barrons.com

2025. g. 25. aug. 13:16 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Are Moving the Most Today: Intel, Wayfair, Strategy, Keurig Dr Pepper, Verint, NIO, Nvidia, and More -- Barrons.com

2025. g. 25. aug. 10:49 UTC

Tirgus saruna

Bitcoin Falls to Six-Week Low as U.S. Rate-Cut Enthusiasm Fades -- Market Talk

2025. g. 25. aug. 10:47 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Are Moving the Most Today: Intel, Wayfair, Strategy, PDD, Keurig Dr Pepper, Verint, Nvidia, and More -- Barrons.com

2025. g. 25. aug. 10:06 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Are Moving the Most Today: Intel, Wayfair, Strategy, Nvidia, Keurig Dr Pepper, Verint Systems, and More -- Barrons.com

2025. g. 25. aug. 09:38 UTC

Peļņas

These Stocks Are Moving the Most Today: Intel, Wayfair, RH, Strategy, Nvidia, Keurig Dr Pepper, and More -- Barrons.com

2025. g. 25. aug. 09:07 UTC

Peļņas

These Stocks Are Moving the Most Today: Intel, Wayfair, RH, Strategy, Nvidia, Keurig Dr Pepper, and More -- Barrons.com

2025. g. 25. aug. 04:13 UTC

Tirgus saruna

Bitcoin's Near-Term Outlook Likely Depends on U.S. Econ Data -- Market Talk

2025. g. 22. aug. 07:12 UTC

Tirgus saruna

Bitcoin Struggles For Meaningful Recovery After Recent Consolidation -- Market Talk

2025. g. 21. aug. 08:10 UTC

Tirgus saruna

Bitcoin's Outlook Depends on Fed Policy Guidance -- Market Talk

2025. g. 21. aug. 07:09 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 21. aug. 07:09 UTC

Tirgus saruna

Bitcoin Falls as Fed Minutes Dampen Rate Cut Bets -- Market Talk

2025. g. 20. aug. 11:09 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 20. aug. 11:09 UTC

Tirgus saruna

Banks Blocking Some U.K. Crypto Investments, IG Research Shows -- Market Talk

2025. g. 20. aug. 07:49 UTC

Tirgus saruna

Bitcoin Continues to Consolidate From Record High -- Market Talk

2025. g. 19. aug. 19:03 UTC

Peļņas

Snail Sees 'Strong Potential to Integrate Stablecoin Functionality Within Our Core Gaming Business'

2025. g. 19. aug. 19:02 UTC

Peļņas

Snail Forms Snail Coins LLC Unit for Stablecoin and Broader Digital Asset Management Initiatives

2025. g. 19. aug. 19:02 UTC

Peļņas

Snail Plans to Develop a Proprietary Stablecoin

2025. g. 19. aug. 10:29 UTC

Iegādes, apvienošanās, pārņemšana

Thumzup to Acquire Dogehash Technologies in All-Stock Transaction

2025. g. 19. aug. 07:09 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 19. aug. 07:09 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 19. aug. 07:09 UTC

Tirgus saruna

Bitcoin Eases Further as Part of Market Correction -- Market Talk

Salīdzinājums

Cenas izmaiņa

NeoGenomics Inc Prognoze

Cenas mērķis

By TipRanks

38.66% augšup

Prognoze 12 mēnešiem

Vidējais 9.29 USD  38.66%

Augstākais 12 USD

Zemākais 8 USD

Pamatojoties uz 10 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

10 ratings

4

Pirkt

6

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

7.7 / 10.27Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.